Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
- 24 May 1995
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 278 (3), 279-283
- https://doi.org/10.1016/0014-2999(95)00181-j
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEuropean Journal of Pharmacology, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Lesions of rostral ventrolateral medulla abolish some cardio- and cerebrovascular components of the cerebellar fastigial pressor and depressor responsesBrain Research, 1990
- Cardiovascular effects of prolonged delta‐9‐tetrahydrocannabinol ingestionCancer Cell, 1975
- Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-Δ9-trans-tetrahydrocannabinolJournal of Pharmacy and Pharmacology, 1974